208 related articles for article (PubMed ID: 308022)
1. Properties of midecamycin, a new macrolide antibiotic.
Salhi A; Vindel JA; Brunaud M; Berceaux G; Marin A; Wuatelet C
G Ital Chemioter; 1977; 24(1-2):67-76. PubMed ID: 308022
[No Abstract] [Full Text] [Related]
2. Bacteriological evaluation of midecamycin acetate and its metabolites.
Yoshida T; Watanabe T; Shomura T; Someya S; Okamoto R; Ishihara S; Miyauchi K; Kazuno Y
Jpn J Antibiot; 1982 Jun; 35(6):1462-74. PubMed ID: 6982352
[TBL] [Abstract][Full Text] [Related]
3. [Miocamycin: microbiological features].
Renzini G; Scazzocchio F; Selan L
Ann Ist Super Sanita; 1987; 23(4):883-6. PubMed ID: 3502551
[No Abstract] [Full Text] [Related]
4. Comparative study on effects of 14- and 16-membered macrolides on gastrointestinal motility in unanaesthetized dogs.
Nakayoshi T; Izumi M; Shinkai S; Fujita M
Drugs Exp Clin Res; 1988; 14(5):319-25. PubMed ID: 3265375
[TBL] [Abstract][Full Text] [Related]
5. [Controlled clinical trial of a new antibiotic "CM 9164" (Midecacin) in dental and stomatological practice].
Pappalardo G; Caltabiano M; Mattina R
Minerva Stomatol; 1979; 28(3):167-86. PubMed ID: 399319
[TBL] [Abstract][Full Text] [Related]
6. [Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections].
Bertrand A; Jonquet O; Sauvaget J
Pathol Biol (Paris); 1988 May; 36(5):544-7. PubMed ID: 3043354
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of midecamycin, a new macrolide antibiotic.
Neu HC
Antimicrob Agents Chemother; 1983 Sep; 24(3):443-4. PubMed ID: 6639001
[TBL] [Abstract][Full Text] [Related]
8. [Effect of tetracyclines, macrolide antibiotics, and sigmamycin on staphylococci in vitro].
Betinová M
Biologia (Bratisl); 1968; 23(9):675-82. PubMed ID: 4971503
[No Abstract] [Full Text] [Related]
9. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
King A; Phillips I
Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
[TBL] [Abstract][Full Text] [Related]
10. Tolypomycin, a new antibiotic. V. In vitro and in vivo antimicrobial activity.
Kondo M; Oishi T; Tsuchiya K
J Antibiot (Tokyo); 1972 Jan; 25(1):16-24. PubMed ID: 4110839
[No Abstract] [Full Text] [Related]
11. In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: comparison with troleandomycin and erythromycin.
Delaforge M; Sartori E; Mansuy D
Chem Biol Interact; 1988; 68(3-4):179-88. PubMed ID: 3265076
[TBL] [Abstract][Full Text] [Related]
12. [Future development of antibiotics. 5. Macrolide antibiotics].
Inoue M
Nihon Rinsho; 1984 Mar; 42(3):553-9. PubMed ID: 6381795
[No Abstract] [Full Text] [Related]
13. In-vitro activity of RU 28965, a new macrolide, compared to that of erythromycin.
Rolston KV; LeBlanc B; Ho DH
J Antimicrob Chemother; 1986 Feb; 17(2):161-3. PubMed ID: 3700283
[TBL] [Abstract][Full Text] [Related]
14. Effects of macrolide antibiotics on drug metabolism in rats and in humans.
Pessayre D
Int J Clin Pharmacol Res; 1983; 3(6):449-58. PubMed ID: 6381341
[TBL] [Abstract][Full Text] [Related]
15. [Ophthalmological application of acetyl spiramycin].
Mikuni M; Oishi M; Hashi H; Shuda S; Imai M
J Antibiot B; 1966 Dec; 19(6):447-54. PubMed ID: 5298393
[No Abstract] [Full Text] [Related]
16. The microbiological characteristics of troleandomycin.
Cocuzza G
Quad Antibiot; 1975 Jun; ():18-34. PubMed ID: 1088736
[No Abstract] [Full Text] [Related]
17. [Synergism of antibiotic components of the streptogramin group].
Chabbert YA; Courvalin P
Pathol Biol (Paris); 1971; 19(11):613-9. PubMed ID: 4933625
[No Abstract] [Full Text] [Related]
18. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological action of a new benzimidazole derivative. II. Protection against bacterial invasion].
Fernández C; Martin-Escudero U; Izquierdo M
Rev Clin Esp; 1976 Apr; 141(1):57-60. PubMed ID: 948657
[No Abstract] [Full Text] [Related]
20. Participation of erythromycin and carbomycin in combined antibiotic action in vitro.
COLEMAN VR; GUNNISON JB; JAWETZ E
Proc Soc Exp Biol Med; 1953; 83(4):668-70. PubMed ID: 13120847
[No Abstract] [Full Text] [Related]
[Next] [New Search]
